Company Zylox-Tonbridge Medical Technology Co., Ltd.
Equities
2190
CNE100004JD2
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.4 HKD | +1.17% | -6.31% | -16.40% |
May. 09 | Zylox-Tonbridge Medical Technology Co., Ltd. Announces Retirement of Hongze Liang as an Independent Non-Executive Director | CI |
Mar. 22 | Zylox-Tonbridge Shrinks Loss by 31% in Fiscal 2023 | MT |
Business Summary
Number of employees: 765
Sales per Business
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Neurovascular Interventional Devices
72.3
%
| 271 | 69.9 % | 422 | 72.3 % | +55.44% |
Peripheral-vascular Interventional Devices
27.4
%
| 117 | 30.1 % | 160 | 27.4 % | +36.51% |
Others
0.2
%
| - | - | 1 | 0.2 % | - |
Sales per region
HKD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
China
97.3
%
| 379 | 97.7 % | 567 | 97.3 % | +49.54% |
Others
2.7
%
| 9 | 2.3 % | 16 | 2.7 % | +73.96% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Zhong Zhao
CEO | Chief Executive Officer | 57 | 12-11-05 |
Quan Wei Yuan
DFI | Director of Finance/CFO | 46 | 20-12-31 |
Ning Pan
CTO | Chief Tech/Sci/R&D Officer | 58 | 18-12-31 |
Zheng Li
BRD | Director/Board Member | 46 | 19-01-30 |
Yang Xie
BRD | Director/Board Member | 54 | 18-02-28 |
Sau In Kwan
SEC | Corporate Secretary | - | 22-09-04 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Hong Ze Liang
BRD | Director/Board Member | 53 | 21-03-01 |
Yun Qiu
BRD | Director/Board Member | 60 | 21-03-01 |
Hui Wang
BRD | Director/Board Member | 51 | 15-10-31 |
Da Song Wang
BRD | Director/Board Member | 55 | 20-10-12 |
Zhong Zhao
CEO | Chief Executive Officer | 57 | 12-11-05 |
Yang Xie
BRD | Director/Board Member | 54 | 18-02-28 |
Zheng Li
BRD | Director/Board Member | 46 | 19-01-30 |
Jian Ji
BRD | Director/Board Member | 54 | 21-03-01 |
Tao Liu
BRD | Director/Board Member | 44 | 22-05-17 |
Changan Ma
BRD | Director/Board Member | - | Nov. 16 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 7,781,257 | 0 | 0 | 32.53 % |
Stock B | 1 | 324,619,744 | 0 | 8,355,500 ( 2.574 %) | |
Stock C | 1 | 324,619,744 | 213,698,565 ( 65.83 %) | 0 |
Company contact information
Zylox-Tonbridge Medical Technology Co., Ltd.
270 Shuyun Road Cangqian Street
311121, Hangzhou
+86 571 8861 0082
http://www.zyloxtb.comSector
Sales per Business
Sales per region
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.40% | 426M | |
+12.05% | 126B | |
-9.24% | 10.89B | |
+0.29% | 9.02B | |
+36.99% | 5.41B | |
-21.98% | 4.6B | |
+8.02% | 3.44B | |
-10.32% | 2.74B | |
-12.33% | 2.06B | |
-13.53% | 1.96B |
- Stock Market
- Equities
- 2190 Stock
- Company Zylox-Tonbridge Medical Technology Co., Ltd.